4//SEC Filing
Febbo Phillip G. 4
Accession 0001384101-25-000024
CIK 0001384101other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:30 PM ET
Size
8.4 KB
Accession
0001384101-25-000024
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
- Award
Common Stock
2025-02-27+30,589→ 113,003 total - Tax Payment
Common Stock
2025-03-02$34.76/sh−6,754$234,769→ 90,577 total - Tax Payment
Common Stock
2025-02-27$33.84/sh−15,672$530,340→ 97,331 total
Footnotes (3)
- [F1]Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein.
- [F2]Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale.
- [F3]The reporting person is reporting the withholding of 1,688 and 5,066 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 3,323 and 9,976 Restricted Stock Units, respectively, granted on October 2, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person.
Documents
Issuer
VERACYTE, INC.
CIK 0001384101
Entity typeother
Related Parties
1- filerCIK 0001649245
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:30 PM ET
- Size
- 8.4 KB